dc.contributor.author
Janas, Anastasia
dc.contributor.author
Jordan, Jakob
dc.contributor.author
Bertalan, Gergely
dc.contributor.author
Meyer, Tom
dc.contributor.author
Bukatz, Jan
dc.contributor.author
Sack, Ingolf
dc.contributor.author
Senger, Carolin
dc.contributor.author
Nieminen-Kelhä, Melina
dc.contributor.author
Brandenburg, Susan
dc.contributor.author
Kremenskaia, Irina
dc.contributor.author
Krantchev, Kiril
dc.contributor.author
Al-Rubaiey, Sanaria
dc.contributor.author
Mueller, Susanne
dc.contributor.author
Koch, Stefan Paul
dc.contributor.author
Boehm-Sturm, Philipp
dc.contributor.author
Reiter, Rolf
dc.contributor.author
Zips, Daniel
dc.contributor.author
Vajkoczy, Peter
dc.contributor.author
Acker, Gueliz
dc.date.accessioned
2025-07-21T17:15:34Z
dc.date.available
2025-07-21T17:15:34Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/48311
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48034
dc.description.abstract
Introduction: Magnetic Resonance Elastography (MRE) allows the non-invasive quantification of tumor biomechanical properties in vivo. With increasing incidence of brain metastases, there is a notable absence of appropriate preclinical models to investigate their biomechanical characteristics. Therefore, the purpose of this work was to assess the biomechanical characteristics of B16 melanoma brain metastases (MBM) and compare it to murine GL261 glioblastoma (GBM) model using multifrequency MRE with tomoelastography post processing.
Methods: Intracranial B16 MBM (n = 6) and GL261 GBM (n = 7) mouse models were used. Magnetic Resonance Imaging (MRI) was performed at set intervals after tumor implantation: 5, 7, 12, 14 days for MBM and 13 and 22 days for GBM. The investigations were performed using a 7T preclinical MRI with 20 mm head coil. The protocol consisted of single-shot spin echo-planar multifrequency MRE with tomoelastography post processing, contrast-enhanced T1- and T2-weighted imaging and diffusion-weighted imaging (DWI) with quantification of apparent diffusion coefficient of water (ADC). Elastography quantified shear wave speed (SWS), magnitude of complex MR signal (T2/T2*) and loss angle (φ). Immunohistological investigations were performed to assess vascularization, blood-brain-barrier integrity and extent of glucosaminoglucan coverage.
Results: Volumetric analyses displayed rapid growth of both tumor entities and softer tissue properties than healthy brain (healthy: 5.17 ± 0.48, MBM: 3.83 ± 0.55, GBM: 3.7 ± 0.23, [m/s]). SWS of MBM remained unchanged throughout tumor progression with decreased T2/T2* intensity and increased ADC on days 12 and 14 (p<0.0001 for both). Conversely, GBM presented reduced φ values on day 22 (p=0.0237), with no significant alterations in ADC. Histological analysis revealed substantial vascularization and elevated glycosaminoglycan content in both tumor types compared to healthy contralateral brain.
Discussion: Our results indicate that while both, MBM and GBM, exhibited softer properties compared to healthy brain, imaging and histological analysis revealed different underlying microstructural causes: hemorrhages in MBM and increased vascularization and glycosaminoglycan content in GBM, further corroborated by DWI and T2/T2* contrast. These findings underscore the complementary nature of MRE and its potential to enhance our understanding of tumor characteristics when used alongside established techniques. This comprehensive approach could lead to improved clinical outcomes and a deeper understanding of brain tumor pathophysiology.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
elastography
en
dc.subject
B16 melanoma
en
dc.subject
brain metastases
en
dc.subject
biomechanical properties
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
In vivo characterization of brain tumor biomechanics: magnetic resonance elastography in intracranial B16 melanoma and GL261 glioma mouse models
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
1402578
dcterms.bibliographicCitation.doi
10.3389/fonc.2024.1402578
dcterms.bibliographicCitation.journaltitle
Frontiers in Oncology
dcterms.bibliographicCitation.originalpublishername
Frontiers Media SA
dcterms.bibliographicCitation.volume
14
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
39324003
dcterms.isPartOf.eissn
2234-943X